164 related articles for article (PubMed ID: 37604633)
1. Effect of an avatar-based discharge education application on knowledge and behaviour in people after acute coronary syndrome: protocol for a pragmatic prospective randomised controlled trial.
Ellis T; Cheng S; Zecchin R; Zwack C; Hyun K; Zhang L; Gallagher R; Clark R; Redfern J
BMJ Open; 2023 Aug; 13(8):e073621. PubMed ID: 37604633
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial.
Zidan A; Awaisu A; Kheir N; Mahfoud Z; Kaddoura R; AlYafei S; El Hajj MS
BMJ Open; 2016 Nov; 6(11):e012141. PubMed ID: 27864247
[TBL] [Abstract][Full Text] [Related]
4. An avatar-based education application to improve patients' knowledge of and response to heart attack symptoms: A pragmatic randomized controlled trial protocol.
Tongpeth J; Du H; Clark RA
J Adv Nurs; 2018 Nov; 74(11):2658-2666. PubMed ID: 29917255
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of an Avatar application for teaching heart attack recognition and response: A pragmatic randomized control trial.
Tongpeth J; Du H; Barry T; Clark RA
J Adv Nurs; 2020 Jan; 76(1):297-311. PubMed ID: 31566810
[TBL] [Abstract][Full Text] [Related]
6. Impact of a clinical pharmacist on optimising the quality use of medicines according to the acute coronary syndrome (ACS) secondary prevention guidelines and medication adherence following discharge in patients with ACS in Sri Lanka: a prospective non-randomised controlled trial study protocol.
Bagyawantha NMY; Coombes ID; Gawarammana I; Fahim M
BMJ Open; 2023 Feb; 13(2):e059413. PubMed ID: 36759028
[TBL] [Abstract][Full Text] [Related]
7. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
Chow CK; Thiagalingam A; Santo K; Kok C; Thakkar J; Stepien S; Billot L; Jan S; Joshi R; Hillis GS; Brieger D; Chew DP; Rådholm K; Atherton JJ; Bhindi R; Collins N; Coverdale S; Hamilton-Craig C; Kangaharan N; Maiorana A; McGrady M; Shetty P; Thompson P; Rogers A; Redfern J
BMJ Open; 2018 Jan; 8(1):e019463. PubMed ID: 29374674
[TBL] [Abstract][Full Text] [Related]
8. The Australian New Zealand Spontaneous Coronary Artery Dissection (ANZ-SCAD) Registry - A Multi-Centre Cohort Study: Protocol, Background and Significance.
Kim SK; Wing-Lun E; Chandrasekhar J; Puri A; Burgess S; Ford TJ; Kovacic J; Graham RM; Psaltis PJ; Zaman S
Heart Lung Circ; 2022 Dec; 31(12):1612-1618. PubMed ID: 36180304
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation protocol for a multicentre randomised controlled trial to compare Smartphone Cardiac Rehabilitation, Assisted self-Management (SCRAM) versus usual care cardiac rehabilitation among people with coronary heart disease.
Gao L; Maddison R; Rawstorn J; Ball K; Oldenburg B; Chow C; McNaughton S; Lamb K; Amerena J; Nadurata V; Neil C; Cameron S; Moodie M
BMJ Open; 2020 Aug; 10(8):e038178. PubMed ID: 32847918
[TBL] [Abstract][Full Text] [Related]
10. Physical Activity after Cardiac EventS (PACES) - a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: study protocol for a randomised controlled trial.
Herring LY; Dallosso H; Chatterjee S; Bodicoat D; Schreder S; Khunti K; Yates T; Seidu S; Hudson I; Davies MJ
Trials; 2018 Oct; 19(1):537. PubMed ID: 30286797
[TBL] [Abstract][Full Text] [Related]
11. SMARTphone and social media-based Cardiac Rehabilitation and Secondary Prevention (SMART-CR/SP) for patients with coronary heart disease in China: a randomised controlled trial protocol.
Dorje T; Zhao G; Scheer A; Tsokey L; Wang J; Chen Y; Tso K; Tan BK; Ge J; Maiorana A
BMJ Open; 2018 Jun; 8(6):e021908. PubMed ID: 29961032
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the cardiac-diabetes transcare program: protocol for a randomised controlled trial.
Wu CJ; Atherton JJ; MacIsaac RJ; Courtney M; Chang AM; Thompson DR; Kostner K; MacIsaac AI; d'Emden M; Graves N; McPhail SM
BMC Health Serv Res; 2017 Feb; 17(1):109. PubMed ID: 28153000
[TBL] [Abstract][Full Text] [Related]
13. A randomised, feasibility trial of a tele-health intervention for acute coronary syndrome patients with depression ('MoodCare'): study protocol.
O'Neil A; Hawkes AL; Chan B; Sanderson K; Forbes A; Hollingsworth B; Atherton J; Hare DL; Jelinek M; Eadie K; Taylor CB; Oldenburg B
BMC Cardiovasc Disord; 2011 Feb; 11():8. PubMed ID: 21349204
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
15. Hybrid cardiac rehabilitation trial (HYCARET): protocol of a randomised, multicentre, non-inferiority trial in South America.
Serón P; Oliveros MJ; Marzuca-Nassr GN; Lanas F; Morales G; Román C; Muñoz SR; Saavedra N; Grace SL
BMJ Open; 2019 Oct; 9(10):e031213. PubMed ID: 31662385
[TBL] [Abstract][Full Text] [Related]
16. Home-based cardiac rehabilitation: development, implementation and outcome evaluation in patients with coronary artery diseases in Lahore, Pakistan - a mixed-methods study protocol.
Yaqoob A; Barolia R; Ladak L; Hanif A; Khan AH; Sahar W
BMJ Open; 2023 Jun; 13(6):e073673. PubMed ID: 37290941
[TBL] [Abstract][Full Text] [Related]
17. ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial.
Redfern J; Hyun K; Singleton A; Hafiz N; Raeside R; Spencer L; Carr B; Caterson I; Cullen J; Ferry C; Santo K; Hayes A; Leung RWM; Raadsma S; Swinbourne J; Cho JG; King M; Roberts M; Kok C; Jenkins C; Chow C
BMJ Open; 2019 Mar; 9(3):e023863. PubMed ID: 30826759
[TBL] [Abstract][Full Text] [Related]
18. MEDication reminder APPs to improve medication adherence in Coronary Heart Disease (MedApp-CHD) Study: a randomised controlled trial protocol.
Santo K; Chow CK; Thiagalingam A; Rogers K; Chalmers J; Redfern J
BMJ Open; 2017 Oct; 7(10):e017540. PubMed ID: 28993388
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the SUCCESS Health Literacy App for Australian Adults With Chronic Kidney Disease: Protocol for a Pragmatic Randomized Controlled Trial.
Isautier J; Webster AC; Lambert K; Shepherd HL; McCaffery K; Sud K; Kim J; Liu N; De La Mata N; Raihana S; Kelly PJ; Muscat DM;
JMIR Res Protoc; 2022 Aug; 11(8):e39909. PubMed ID: 36044265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
